5-methylcytosine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bao, B; Boerner, JL; Bollig-Fischer, A; Dyson, G; Mitrea, C; Teslow, EA | 1 |
Bollig-Fischer, A; Draghici, S; Dyson, G; Kruger, A; Mitrea, C; Ruden, DM; Wijesinghe, P | 1 |
2 other study(ies) available for 5-methylcytosine and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; DNA-Binding Proteins; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Obesity; Proto-Oncogene Proteins; Serine-Arginine Splicing Factors; Triple Negative Breast Neoplasms | 2020 |
Integrating 5hmC and gene expression data to infer regulatory mechanisms.
Topics: 5-Methylcytosine; Cell Line, Tumor; Computational Biology; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Sequence Analysis, DNA; Sequence Analysis, RNA; Triple Negative Breast Neoplasms | 2018 |